Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,339 | -7,038 | -13,986 | -15,612 | -16,134 |
| Depreciation Amortization | 85 | 608 | 984 | 1,767 | 7,271 |
| Accounts receivable | 165 | -762 | 184 | 592 | -40 |
| Other Working Capital | -26 | -1,446 | -3,508 | 118 | -4,263 |
| Other Operating Activity | -2,624 | -989 | 1,032 | -842 | -12,702 |
| Operating Cash Flow | $-4,739 | $-9,627 | $-15,294 | $-13,977 | $-25,868 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -7,525 | N/A | N/A |
| PPE Investments | N/A | 318 | 110 | 848 | -988 |
| Net Acquisitions | N/A | -2,000 | 569 | 569 | -4,250 |
| Sale Of Investment | N/A | 5,024 | 2,502 | N/A | 21,846 |
| Purchase Sale Intangibles | 750 | 4,000 | N/A | N/A | N/A |
| Other Investing Activity | 750 | 4,000 | 0 | 0 | 0 |
| Investing Cash Flow | $750 | $7,342 | $-4,344 | $1,417 | $16,608 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2,146 |
| Common Stock Issued | 6 | 9 | 6,009 | 5,007 | 25,208 |
| Other Financing Activity | 0 | 0 | -497 | -488 | -1,162 |
| Financing Cash Flow | $6 | $9 | $5,512 | $4,519 | $21,900 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 2 |
| Beginning Cash Position | 4,242 | 6,518 | 20,644 | 28,685 | 16,043 |
| End Cash Position | 259 | 4,242 | 6,518 | 20,644 | 28,685 |
| Net Cash Flow | $-3,983 | $-2,276 | $-14,126 | $-8,041 | $12,642 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,739 | -9,627 | -15,294 | -13,977 | -25,868 |
| Capital Expenditure | N/A | -16 | -5 | -72 | -1,007 |
| Free Cash Flow | -4,739 | -9,643 | -15,299 | -14,049 | -26,875 |